Skip to content

Income Tax at other companies

Royalty Pharma logo
Royalty PharmaRPRX
$0
LQD
Liquidia CorporationLQDA
$3.92M
Revvity logo
RevvityRVTY
$9.1M-15.1%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$10.09M+43.6%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$79K-4.8%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$218K+87.9%

Other financials

Income statement

See full
Revenue$51.7M+14.1%
Operating income$17.4M+148%
Net income-$13.3M+68.6%
EPS (diluted)-$0.67+69.7%

Balance sheet

See full
Cash & equivalents$115.1M+140%
Total debt$5.1M+14.2%
Total equity$997.3M+25.4%
Total assets$1.5B+69.2%

Cash flow

See full
Operating cash flow$48.7M+291%
CapEx$228.0K+6.5%
Free cash flow$48.5M+289%

Valuation

See full
Market cap$5.6B+96.7%

Profitability

See full
Gross margin91.9%
Operating margin34.5%+23.0pp
Net margin55.9%+35.7pp
FCF margin44.8%+16.8pp

Returns & leverage

See full
Return on equity17.1%+11.5pp
Debt / equity0.0×
Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ligand Pharmaceuticals's income tax?
Ligand Pharmaceuticals (LGND) reported income tax of -$10.91M in Q1 2026.
How has Ligand Pharmaceuticals's income tax changed year-over-year?
Ligand Pharmaceuticals's income tax decreased by 41.2% year-over-year, from -$7.73M to -$10.91M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.